William W. Li, MD
President, Medical Director and CEO
The Angiogenesis Foundation
Dr. William W. Li is CEO of the Angiogenesis Foundation, a social enterprise dedicated to fighting diseases through their common denominators. Dr. Li leads international efforts to develop new therapeutic strategies for major diseases in collaboration with academia, government, industry, and advocacy associations. His work resulted in 34 FDA-approved treatments for cancer, blindness, and wound healing impacting over 50 million people worldwide. Dr. Li now focuses on food as medicine and is leading a global effort to understand the vascular pathology of COVID-19 and its consequences. Dr. Li has authored more than 100 scientific publications in journals such as Science, New England Journal of Medicine, The Lancet, and Nature Reviews, and he served on the faculties of Harvard and Dartmouth Medical Schools. A graduate of Harvard College and the University of Pittsburgh School of Medicine, Dr. Li completed his residency at Massachusetts General Hospital.